Postnatal glucocorticoid therapy for prevention of bronchopulmonary dysplasia: routes of administration compared

Rojas, 1995, Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease, J Pediatr, 126, 605, 10.1016/S0022-3476(95)70362-4 Jobe, 1999, The new BPD: an arrest in lung development, Pediatr Res, 46, 641, 10.1203/00006450-199912000-00007 Coalson, 1999, Pathology of lung disease of early infancy, 85 Jobe, 1998, Mechanisms initiating lung injury in the preterm, Early Hum Dev, 53, 81, 10.1016/S0378-3782(98)00045-0 Pierce, 1995, The role of inflammation in the pathogenesis of bronchoplumonary dysplasia, Pediatric Pulmonol, 19, 371, 10.1002/ppul.1950190611 Speer, 1999, Inflammatory mediators in neonatal CLD, 147 Watterberg, 1996, Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops, Pediatr, 97, 210, 10.1542/peds.97.2.210 Cole, 2000, Strategies for prevention of neonatal chronic lung disease, 445 Barnes, 1998, Efficacy and safety of inhaled corticosteroids, Am J Respr Crit Care Med, 157, S1, 10.1164/ajrccm.157.3.157315 Jaffuel, 2000, Transcriptional potencies of inhaled glucocorticoids, Am J Respr Care Med, 162, 57, 10.1164/ajrccm.162.1.9901006 Lipworth, 2000, Therapeutic implications of non-genomic glucocorticoid activity, Lancet, 356, 87, 10.1016/S0140-6736(00)02463-6 Thebaud, 2001, Postnatal glucocorticoids in very preterm infants: ‘The good, the bad, and the ugly’?, Pediatrics, 107, 413, 10.1542/peds.107.2.413 Almeida, 2000, Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate, FASEB J, 14, 779, 10.1096/fasebj.14.5.779 Finer, 2000, Postnatal steroids: short-term gain, long-term pain?, J Pediatr, 137, 9, 10.1067/mpd.2000.107799 Barrington, KJ, The adverse neurodevelopmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs, http:/www.biomedcentral.com/1471-2431/1/1/ Watterberg, 1999, Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants, Pediatrics, 104, 1258, 10.1542/peds.104.6.1258 Andre, 2000, Methylprednisolone, an alternative to dexamethasone in very premature infants at risk for chronic lung disease, Intensive Care Med, 26, 1496, 10.1007/s001340000588 Shah, VS, Ohlsson, A, Halliday, H, Dunn, MS, Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants (protocol), 2000 Halliday, HL, Ehrenkranz, RA, Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease inpreterm infants (Review), 2000 Halliday, HL, Ehrenkranz, RA, Moderately early (7–14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Review), 2000 Halliday, HL, Ehrenkranz, RA, Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Review), 2000 Doyle, 2000, Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function, J Paediatr Child Health, 36, 101, 10.1046/j.1440-1754.2000.00481.x Kothadia, 1999, Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator ventilator dependency in very low birthweight infants, Pediatrics, 104, 22, 10.1542/peds.104.1.22 Noble-Jamieson, 1989, Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications, Eur J Pediatr, 148, 365, 10.1007/BF00444135 O'Shea, 1999, Randomized placebo-controlled trial of a 42 day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age, Pediatrics, 104, 15, 10.1542/peds.104.1.15 Bhuta, 1998, Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease, Arch Dis Child Fetal Neonatal Ed, 79, F26, 10.1136/fn.79.1.F26 Arias-Camison, JM, Lau, J, Cole, CH, Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants, Pediatr Pulmonol, 1999, 28, 167, 174, 1999 Kari, 1993, Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia, Arch Dis Child, 68, 566, 10.1136/adc.68.5_Spec_No.566 Cummings, 1989, A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia, N Engl J Med, 320, 1505, 10.1056/NEJM198906083202301 Garland, 1999, A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomised trial, Pediatrics, 104, 91, 10.1542/peds.104.1.91 Soll, 1999, Early postnatal dexamethasone therapy for the prevention of chronic lung disease, Pediatr Res, 45, 226A, 10.1203/00006450-199904020-01345 Stark, 2001, Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants, N Engl J Med, 344, 95, 10.1056/NEJM200101113440203 Shinwell, 2000, Early postnatal dexamethasone therapy is associated with increased incidence of cerebral palsy, Arch Dis Child Fetal Neonatal Ed, 83, F177, 10.1136/fn.83.3.F177 Yeh, 1998, Early postnatal dexamethasone therapy for prevention of BPD in preterm infants with RDS: a two-year follow-up study, Pediatrics, 101, 10.1542/peds.101.5.e7 Watterberg, 1995, Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia, Pediatr, 95, 120, 10.1542/peds.95.1.120 Cole, 2000, Inhaled glucocorticoid therapy in infants at risk for neonatal chronic lung disease, J Asthma, 37, 533, 10.3109/02770900009090808 Lister, P, Iles, R, Shaw, B, Ducharme, F, Inhaled steroids for neonatal chronic lung disease, 2000 Shah, V, Ohlsson, A, Halliday, HL, Dunn, MS, Early Administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates (Review), 2000 LaForce, 1993, Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infants, J Pediatr, 122, 285, 10.1016/S0022-3476(06)80134-4 Arnon, 1996, Effectiveness of budesonide aerosol in ventilator-dependent preterm babies: a preliminary report, Pediatr Pulmonol, 21, 231, 10.1002/(SICI)1099-0496(199604)21:4<231::AID-PPUL5>3.0.CO;2-R Yuksel, 1992, Ranodomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow-up, Thorax, 47, 910, 10.1136/thx.47.11.910 Cole, 1999, Early inhaled glucocorticoid therapy for prevention of bronchopulmonary dysplasia, N Engl J Med, 340, 1005, 10.1056/NEJM199904013401304 Mertz, 1999, Inhaled budesonide in ventilator-dependent preterm infants: a randomized, double-blind pilot study, Biol Neonate, 75, 46, 10.1159/000014076 Fok, 1999, Randomized controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome, Arch Dis Child Fetal Neonatal Ed, 80, F203, 10.1136/fn.80.3.F203 Denjean, 1998, Inhaled salbutamol and beclomethasone for preventing bronchopulmonary dysplasia: a randomised double-blind study, Eur J Pediatr, 157, 926, 10.1007/s004310050969 Gupta, 2000, Effect of beclomethasone therapy on tracheal aspirate interleukin-8 and interleukin-1 receptor antagonist in preterm ventilated infants at risk for bronchopulmonary dysplasia (BPD), Pediatr Pulmonol, 30, 275, 10.1002/1099-0496(200010)30:4<275::AID-PPUL1>3.0.CO;2-G Abbasi, 1999, Effect of early glucocorticoid therapy on tracheobronchial lesions in mechanically ventilated preterm infants, Pediatr Res, 45, 179A Cole, 1999, Adrenal function in premature infants during inhaled beclomethasone therapy, J Pediatr, 135, 65, 10.1016/S0022-3476(99)70329-X Ng, 1998, Pituitary-adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment, J Clin Endo Metab, 83, 2390, 10.1210/jcem.83.7.4947 Dimitriou, 1997, Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants, Eur J Pediatr, 156, 51, 10.1007/s004310050552 Groneck, 1999, Effects of inhaled beclomethasone compared to systemic dexamethasone on lung inflammation in preterm infants at risk of chronic lung disease, Pediatr Pulmonol, 27, 383, 10.1002/(SICI)1099-0496(199906)27:6<383::AID-PPUL4>3.0.CO;2-V Halliday, 2001, A multicenter, randomized, open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: a comparison of early and late treatment of dexamethasone and inhaled budesonide, Pediatrics, 107, 232, 10.1542/peds.107.2.232 Kovacs, 1998, Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity, Acta Paediatr, 87, 792, 10.1111/j.1651-2227.1998.tb01749.x Cole, 2001, The use of aerosolized medicines in neonates, 1